Adalat® in the Asian Pacific Region

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Adalat® in the Asian Pacific Region by , Springer Berlin Heidelberg
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642749117
Publisher: Springer Berlin Heidelberg Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9783642749117
Publisher: Springer Berlin Heidelberg
Publication: December 6, 2012
Imprint: Springer
Language: English

These are the proceedings of the third Asian Pacific Adalat Symposium. The first was held in Tokyo in 1982 and the second in Sydney in 1985. We were honoured that the late Dr. Sukaman and his colleagues were able to host this third symposium in Jakarta. This meeting was designed to contribute to and to promote international collaboration in cardiovascular research, and to help promote further knowledge and understanding about the treatment of vascular disease in the Asian Pacific area. Nifedipine was originally investigated in the mid-1960s by Prof. Fleckenstein. His first results showed this drug was a powerful calcium antagonist which altered excitation contraction. At this time, there was a rapid development of knowledge about the pathophysiology of ischaemic heart disease, and thus the important pharmacological work on calcium antagonists such as nifedipine paralleled and complimented the newer understanding of coronary physiology in man. In a short time most therapy was designed to reduce myocardial oxygen consumption and demand.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

These are the proceedings of the third Asian Pacific Adalat Symposium. The first was held in Tokyo in 1982 and the second in Sydney in 1985. We were honoured that the late Dr. Sukaman and his colleagues were able to host this third symposium in Jakarta. This meeting was designed to contribute to and to promote international collaboration in cardiovascular research, and to help promote further knowledge and understanding about the treatment of vascular disease in the Asian Pacific area. Nifedipine was originally investigated in the mid-1960s by Prof. Fleckenstein. His first results showed this drug was a powerful calcium antagonist which altered excitation contraction. At this time, there was a rapid development of knowledge about the pathophysiology of ischaemic heart disease, and thus the important pharmacological work on calcium antagonists such as nifedipine paralleled and complimented the newer understanding of coronary physiology in man. In a short time most therapy was designed to reduce myocardial oxygen consumption and demand.

More books from Springer Berlin Heidelberg

Cover of the book Chemical Ocular Burns by
Cover of the book Ages, Geochemistry and Metamorphism of Neoarchean Basement in Shandong Province by
Cover of the book Aging Hair by
Cover of the book Power from Pellets by
Cover of the book Ergotherapeutische Behandlungsansätze bei Demenz und dem Korsakow-Syndrom by
Cover of the book An der Hochschule lehren by
Cover of the book Nuclear Hepatology by
Cover of the book Mental Health in the Elderly by
Cover of the book Exploration of Gas Hydrates by
Cover of the book Modern Imaging of the Alimentary Tube by
Cover of the book Proceedings of the 37th International Symposium on Archaeometry, 13th - 16th May 2008, Siena, Italy by
Cover of the book Medical Decision Making by
Cover of the book Recent Development in Clusters of Rare Earths and Actinides: Chemistry and Materials by
Cover of the book Ancestors, Territoriality, and Gods by
Cover of the book Begleitung von Flüchtlingen mit traumatischen Erfahrungen by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy